Nanoparticle mediated delivery of 2′-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanoparticle mediated delivery of 2′-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells

Published:2010-06 Issue:3 Volume:68 Page:346-354
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Beisner Julia,Dong Meng,Taetz Sebastian,Nafee Noha,Griese Ernst-Ulrich,Schaefer Ulrich,Lehr Claus-Michael,Klotz Ulrich,Mürdter Thomas E.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference35 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995;311(October (7010)):899–909.

3. Current status of adjuvant chemotherapy in NSCLC;Scagliotti;Ann Oncol,2006

4. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats;Morin;Cell,1989

5. The RNA component of human telomerase;Feng;Science,1995

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics;International Journal of Nanomedicine;2024-04

2. Current Progress in Targeting Telomere and Telomerase Enzymes for the Treatment of Cancer;Current Cancer Therapy Reviews;2024-01

3. Telomerase: a nexus between cancer nanotherapy and circadian rhythm;Biomaterials Science;2024

4. Chitosan nanoparticles for gene delivery in cancer therapy and disease diagnosis;Cancer Therapy;2024

5. Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy;Biomedicines;2023-06-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3